Clopidogrel Bisulfate

Especificaciones

120202-66-6Número CAS

601-679-1Número CE

methyl (2S)-2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate;sulfuric acidNombre IUPAC

C16H18ClNO6S2Fórmula química

419.9 g/molPeso molecular

Clopidogrel bisulfate; 120202-66-6; CLOPIDOGREL SULFATE; Clopidogrel bisulphate; Clopidogrel hemisulfate; clopidogrel hydrogen sulphate; Clopidogrel BMS; Isocover; Pidogrel; Clopidogrel-bgr; Clopidogrel-bms; Clopidogrel teva; SR 25990C; Clopidogrel zentiva; Clopidogrel (as bisulfate); SR-25990C; Clopidogrel ratiopharm; 08I79HTP27; CLOPIDOGREL (AS HYDROGEN SULFATE); DTXSID601016080; DUOCOVER COMPONENT CLOPIDOGREL BISULFATE; DUOPLAVIN COMPONENT CLOPIDOGREL BISULFATE; Thieno(3,2-c)pyridine-5(4H)-acetic acid, alpha-(2-chlorophenyl)-6,7-dihydro-, methyl ester, (S)-, sulfate (1:1); CLOPIDOGREL/ACETYLSALICYCLIC ACID TEVA COMPONENT CLOPIDOGREL BISULFATE; CHEBI:3759; Clopidogrel 75mg; RefChem:54857; DTXCID2026024; 686-767-8; Methyl (2S)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno(3,2-c)pyridin-5(4H)-yl)acetate monosulfate; Clopidogrel hydrogen sulfate; Plavix; (S)-methyl 2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate sulfate; S-(+)-Clopidogrel Hydrogen Sulfate; Clopidogrel (hydrogen sulfate); Clopidogrel (Plavix); 144077-07-6; MFCD00876395; Thieno[3,2-c]pyridine-5(4H)-acetic acid,a-(2-chlorophenyl)-6,7-dihydro-, methyl ester, (aS)-, sulfate (1:1); C16H18ClNO6S2; PM-103; methyl (2S)-2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate;sulfuric acid; Myogrel; Clopidogrel hydrogensulfate; Plavix (TN); methyl (S)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate sulfate; Clopidogrel sulphate; Plavitor; Osvix; (S)-(+)-Methyl (2-chlorophenyl)(6,7-dihydro-4H-thieno[3,2-c]pyrid-5-yl)acetate sulfate; CHEMBL1083385; sulfuric acid methyl (2S)-2-(2-chlorophenyl)-2-{4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl}acetate; Clopidogrel Bisulfate [USAN]; UNII-08I79HTP27; Clopidogrel bisulfate [USAN:USP]; Isocover (TN); 120202-66-6 (sulfate); Methyl (S)-2-(2-Chlorophenyl)-2-[6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]acetate Sulfate; Clopidogrel bisolfato; bisulfato de clopidogrel; bissulfato de clopidogrel; Clopido grel hemisulfate; (+) Clopidogrel Bisulfate; Methyl alphaS-(2-chlorophenyl)-6,7-dihydrothieno(3,2-c)pyridine-5(4H)-acetate sulfate (1:1); Clopidogrel bisulfate (USP); Clopidogrel sulfate (JP18); SCHEMBL33556; SCHEMBL33558; SPECTRUM1503710; MDCO-157; orb1310861; Clopidogrel hydrogen sulfate CRS; CLOPIDOGREL SULFATE [JAN]; GLXC-07573; HMS1922G16; HMS2093I13; HMS3884G15; Pharmakon1600-01503710; Clopidogrel sulfate tablets (JP18); CCG-39568; CLOPIDOGREL BISULFATE [VANDF]; EBC-07538; HY-17459R; MFCD05865229; NSC758613; s1415; T0182L; CLOPIDOGREL BISULFATE [MART.]; AKOS015900408; CLOPIDOGREL BISULFATE [USP-RS]; CLOPIDOGREL BISULFATE [WHO-DD]; Clopidogrel for system suitability CRS; AC-2135; CS-1882; DV-7314; FC11669; FC20513; KS-1045; methyl (2S)-2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate sulfate; CLOPIDOGREL HYDROGEN SULFATE [MI]; 111GE004; BC164326; HY-17459; Methyl (+)-(S)-alpha-(o-chlorophenyl)-6,7-dihydrothieno(3,2-c)pyridine-5(4H)-acetate, sulfate (1:1); SY070710; Thieno(3,2-c)pyridine-5(4H)-acetic acid, 6,7-dihydro-alpha-(2-chlorophenyl)-, methyl ester, (S)-, sulfate; Thieno(3,2-c)pyridine-5(4H)-acetic acid, alpha-(2-chlorophenyl)-6,7-dihydro-, methyl ester, (alphaS)-, sulfate (1:1); Clopidogrel (hydrogen sulfate) (Standard); CLOPIDOGREL BISULFATE [ORANGE BOOK]; DB-224817; C2556; C4658; CLOPIDOGREL BISULFATE [USP MONOGRAPH]; SW219457-1; CLOPIDOGREL HYDROGEN SULFATE [EMA EPAR]; D00769; EN300-122370; CLOPIDOGREL HYDROGEN SULPHATE [EMA EPAR]; CLOPIDOGREL HYDROGEN SULFATE [EP MONOGRAPH]; F092016; SR-05000002068; SR-05000002068-1; (S)-(+)-Clopidogrel hydrogensulfate, >=98% (HPLC); Q27888063; S-(+)-Clopidogrel hydrogen sulfate - Bio-X trade mark; Z1541759896; (S)-(+)-Clopidogrel bisulfate;(S)-(+)-Clopidogrel hydrogen sulfate; Clopidogrel bisulfate, United States Pharmacopeia (USP) Reference Standard; Clopidogrel hydrogen sulfate, European Pharmacopoeia (EP) Reference Standard; (S)-(+)-Methyl (2-chlorophenyl)(6,7-dihydro-4H-thieno(3,2-c)pyrid-5-yl)acetate bisulfate; Clopidogrel Bisulfate, Pharmaceutical Secondary Standard; Certified Reference Material; Clopidogrel for system suitability, European Pharmacopoeia (EP) Reference Standard; methyl(S)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetatesulfate; (S)-(+)-Methyl 2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate hydrogen sulfate; (S)-(2-Chloro-phenyl)-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)-acetic acid methyl ester sulfuric acid salt; (S)-METHYL-(2-CHLORO-PHENYL)-(6,7-DIHYDRO-4H-THIENO[3,2-C]PYRIDIN-5-YL)-ACETATE H2SO4; 120202-48-4; METHYL (+)-(S)-.ALPHA.-(O-CHLOROPHENYL)-6,7-DIHYDROTHIENO(3,2-C)PYRIDINE-5(4H)-ACETATE, SULFATE (1:1); METHYL (+)-(S)-.ALPHA.-(O-CHLOROPHENYL)-6,7-DIHYDROTHIENO(3,2-C)PYRIDINE-5(4H)-ACETATE, SULPHATE (1:1); methyl (2S)-2-(2-chlorophenyl)-2-{4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl}acetate; sulfuric acid; Methyl (S)-(+)-2-(2-Chlorophenyl)-2-[6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl]acetate Sulfate; Sulfuric acid--methyl (2S)-(2-chlorophenyl)(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate (1/1); THIENO(3,2-C)PYRIDINE-5(4H)-ACETIC ACID, .ALPHA.-(2-CHLOROPHENYL)-6,7-DIHYDRO-, METHYL ESTER, (S)-, SULFATE (1:1); THIENO(3,2-C)PYRIDINE-5(4H)-ACETIC ACID, .ALPHA.-(2-CHLOROPHENYL)-6,7-DIHYDRO-, METHYL ESTER, (S)-, SULPHATE (1:1)Sinónimos